Markets
CNS

Health Care Sector Update for 12/16/2015: MRNS, BIIB, ALKS

Top Health-care stocks:

JNJ: +0.5%

PFE: +0.7%

ABT: flat

MRK: +1.7%

AMGN: flat

Health-care shares were mainly higher in pre-market trade on Wednesday.

In health-care stocks news, Marinus Pharmaceuticals ( MRNS ), which focuses on the development of treatments for epilepsy and neuropsychiatric disorders, said it has completed patient recruitment for the Phase 3 clinical trial of ganaxolone, a CNS-selective GABAA modulator, in adults with drug-resistant focal onset seizures.

Shares in the company were unchanged at $6.12 pre-bell. This is within the lower band of the stock's 52 week trading range between $4.52 and $20.72.

Biogen ( BIIB ), a global biopharmaceutical company, is collaborating with Arsia Therapeutics in the development of subcutaneous injection versions of the intravenous treatment for hemophilia.

The company was also inactive pre-bell at $289.11. This is within the lower band of the stock's 52 week trading range between $254 and $480.18.

And biopharmaceutical company Alkermes ( ALKS ) reported Wednesday new developments and milestones related to its proprietary product and late-stage pipeline portfolio of medicines for the treatment of central nervous system ( CNS ) diseases.

Shares were flat at $72.74 pre-bell. This is within the upper band of the stock's 52 week trading range between $53.01 and $75.99.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CNS MRNS BIIB ALKS

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More